NewsBenzinga美国食品和药物管理局批准默克公司与来那替尼联合使用贝唑替芬治疗晚期清除细胞成分肾癌 美国食品和药物管理局批准默克公司与来那替尼联合使用贝唑替芬治疗晚期清除细胞成分肾癌 Benzinga 2026.09.24 19:21 (GMT+0) Open on Benzinga Other news Canaccord Genuity Maintains Buy on Belite Bio, Raises Price Target to $314 Applied Optoelectronics Stock Sinks Amid AI Outlook Fears Canaccord Genuity Maintains Buy on Enovix, Lowers Price Target to $2.5 Canaccord Genuity Maintains Buy on Intuitive Machines, Lowers Price Target to $38 'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report Canaccord Genuity Maintains Buy on Nektar Therapeutics, Lowers Price Target to $149
'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report